Gene · 1420
Papers1,603
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,603
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models. | Biomedicines | 2023 | 37893198 | PubTator, text mining | PubMed |
| Spatiotemporal evolution of AML immune microenvironment remodeling and RNF149-driven drug resistance through single-cell multidimensional analysis. | J Transl Med | 2023 | 37891580 | PubTator, text mining | PubMed |
| Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review). | Mol Med Rep | 2023 | 37888611 | PubTator, text mining | PubMed |
| Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity. | Front Immunol | 2023 | 37881427 | PubTator, text mining | PubMed |
| CRISPR/Cas9 technology: applications in oocytes and early embryos. | J Transl Med | 2023 | 37875936 | PubTator, text mining | PubMed |
| Macrophage polarization in tissue fibrosis. | PeerJ | 2023 | 37849830 | PubTator, text mining | PubMed |
| Mimicking lipolytic, adipogenic, and secretory capacities of human subcutaneous adipose tissue by spheroids from distinct subpopulations of adipose stromal/stem cells. | Front Cell Dev Biol | 2023 | 37842092 | PubTator, text mining | PubMed |
| Mechanisms underlying the beneficial effects of physical exercise on multiple sclerosis: focus on immune cells. | Front Immunol | 2023 | 37841264 | PubTator, text mining | PubMed |
| Inflammatory loops in the epithelial-immune microenvironment of the skin and skin appendages in chronic inflammatory diseases. | Front Immunol | 2023 | 37841246 | PubTator, text mining | PubMed |
| Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches. | Int J Mol Sci | 2023 | 37834153 | PubTator, text mining | PubMed |
| Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis. | Cells | 2023 | 37830598 | PubTator, text mining | PubMed |
| New insight into the role of fibroblasts in the epithelial immune microenvironment in the single-cell era. | Front Immunol | 2023 | 37809065 | PubTator, text mining | PubMed |
| The mechanism of dendritic cell-T cell crosstalk in rheumatoid arthritis. | Arthritis Res Ther | 2023 | 37798668 | PubTator, text mining | PubMed |
The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour. | Int J Mol Sci | 2023 | 37762403 | PubTator, text mining | PubMed |
| NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases. | Cells | 2023 | 37759549 | PubTator, text mining | PubMed |
| T Lymphocytes and Their Potential Role in Dementia with Lewy Bodies. | Cells | 2023 | 37759503 | PubTator, text mining | PubMed |
| The Role of Organokines in Obesity and Type 2 Diabetes and Their Functions as Molecular Transducers of Nutrition and Exercise. | Metabolites | 2023 | 37755259 | PubTator, text mining | PubMed |
| Investigation of the association between habitual dietary FODMAP intake, metabolic parameters, glycemic status, and anthropometric features among apparently healthy overweight and obese individuals. | BMC Endocr Disord | 2023 | 37752490 | PubTator, text mining | PubMed |
| A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study. | QJM | 2023 | 37740371 | PubTator, text mining | PubMed |
| ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis. | Hum Genomics | 2023 | 37735492 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1420/papers?page=8